The Role of Mesenchymal Stem Cells in the Functional Improvement of Chronic Renal Failure
Authors:
- 1 April 2009
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 18 (3) , 521-530
Abstract
The most commonly used therapeutic targets in nephrology are the reduction of injury, the delay of progression, or renal replacement therapy. Many animal and human studies demonstrated the role of stem cells in repair and regenerations of kidney. Mesenchymal stem cells (MSCs) have shown to improve outcome of acute renal injury models. It is controversial whether MSCs can reduce injury following a toxic/ischemic event and delay renal failure in chronic kidney disease. We evaluated the hypothesis that the treatment with MSCs could improve renal function and attenuate injury in chronic renal failure (CRF). Sprague–Dawley female rats (8 weeks old, 182.2 ± 7.2 g) underwent modified 5/6 nephrectomy. Rats in the MSC group received an injection of MSCs (1 × 10 6 cells) via tail vein 1 day after nephrectomy. Blood and urine samples were collected after 7 days and every month thereafter. The kidneys of rats were removed for histologic evaluation after 24-h urine collection and blood sampling. The Y-chromosome stain using fluorescent in situ hybridization was performed to verify the presence of male MSCs in the kidney of female recipients. No significant differences in blood urea nitrogen and creatinine concentration were observed between the MSC group and the untreated CRF group. However, the weight gain in the MSC group was greater than those in the CRF group after 4 months. Proteinuria in the MSC group was less than that in the CRF group over time. Y chromosome was detected in the kidney of MSC group. Although no significances were observed between these two groups, the histologic analysis suggests that MSCs have positive effect against glomerulosclerosis. These results suggest that MSCs help preserve renal function and attenuate renal injury in CRF.Keywords
This publication has 32 references indexed in Scilit:
- Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient miceKidney International, 2006
- Erythropoietin Delivery by Genetically Engineered Bone Marrow Stromal Cells for Correction of Anemia in Mice with Chronic Renal FailureJournal of the American Society of Nephrology, 2006
- Stem Cell Approaches for the Treatment of Renal FailurePharmacological Reviews, 2005
- Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis ImperfectaTransplantation, 2005
- Progenitor cells in the kidney: Biology and therapeutic perspectivesKidney International, 2004
- Bone marrow contributes to renal parenchymal turnover and regenerationThe Journal of Pathology, 2001
- Stem CellsCell, 2000
- VEGF165 mediates glomerular endothelial repairJournal of Clinical Investigation, 1999
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli.Journal of Experimental Medicine, 1979